BioLife Solutions Inc (BLFS)
21.96
-0.01
(-0.05%)
USD |
NASDAQ |
May 17, 16:00
21.94
-0.02
(-0.07%)
After-Hours: 20:00
BioLife Solutions Enterprise Value: 989.87M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 989.87M |
May 16, 2024 | 990.33M |
May 15, 2024 | 1.037B |
May 14, 2024 | 1.012B |
May 13, 2024 | 930.03M |
May 10, 2024 | 878.47M |
May 09, 2024 | 808.04M |
May 08, 2024 | 804.82M |
May 07, 2024 | 835.20M |
May 06, 2024 | 814.49M |
May 03, 2024 | 808.96M |
May 02, 2024 | 808.75M |
May 01, 2024 | 777.68M |
April 30, 2024 | 780.42M |
April 29, 2024 | 795.04M |
April 26, 2024 | 779.97M |
April 25, 2024 | 749.35M |
April 24, 2024 | 764.43M |
April 23, 2024 | 756.66M |
April 22, 2024 | 746.61M |
April 19, 2024 | 703.66M |
April 18, 2024 | 703.66M |
April 17, 2024 | 670.77M |
April 16, 2024 | 710.06M |
April 15, 2024 | 695.44M |
Date | Value |
---|---|
April 12, 2024 | 732.91M |
April 11, 2024 | 760.32M |
April 10, 2024 | 767.63M |
April 09, 2024 | 808.75M |
April 08, 2024 | 769.91M |
April 05, 2024 | 761.69M |
April 04, 2024 | 779.05M |
April 03, 2024 | 770.37M |
April 02, 2024 | 783.16M |
April 01, 2024 | 796.87M |
March 31, 2024 | 826.57M |
March 28, 2024 | 813.76M |
March 27, 2024 | 809.69M |
March 26, 2024 | 793.38M |
March 25, 2024 | 825.09M |
March 22, 2024 | 816.94M |
March 21, 2024 | 800.63M |
March 20, 2024 | 784.77M |
March 19, 2024 | 772.54M |
March 18, 2024 | 743.55M |
March 15, 2024 | 758.04M |
March 14, 2024 | 755.33M |
March 13, 2024 | 771.18M |
March 12, 2024 | 727.69M |
March 11, 2024 | 742.64M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
167.67M
Minimum
Mar 16 2020
2.430B
Maximum
Sep 01 2021
836.70M
Average
795.88M
Median
Enterprise Value Benchmarks
Align Technology Inc | 19.54B |
ThermoGenesis Holdings Inc | 8.406M |
NeuroOne Medical Technologies Corp | 25.32M |
SINTX Technologies Inc | 4.900M |
Nutriband Inc | 48.75M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -10.22M |
Revenue (Quarterly) | 31.73M |
Total Expenses (Quarterly) | 41.62M |
EPS Diluted (Quarterly) | -0.22 |
Gross Profit Margin (Quarterly) | 39.59% |
Profit Margin (Quarterly) | -32.22% |
Earnings Yield | -6.47% |
Normalized Earnings Yield | -5.846 |